Statistical Considerations for Implementing the FDA CV Guidance for T2DM Craig Wilson, PhD NIC-ASA Fall Meeting October 15, 2009.
AKT Guidance from trainees whove done it.. AIMS What is the AKT? Why do I need to do it? When do I need to do it? Where do I need to do it? How do I need.
1 Clinical Epidemiology Using Evidence to Guide Practice A bit of thinking and a few simple sums.
BUILDING SHARPE OPTIMIZATION STOCK PORTFOLIOS AND PERFORMANCE ANALYSIS.
How can we improve the quality of Cochrane Reviews (in 8 minutes)? David Tovey.
Guidelines for Antiviral Treatment of Adults and Adolescents with HIV-1 (including 2011-2013 changes, and a little extra on what else is new and current)
1 Topic 4 (Ch. 9) The Capital Asset Pricing Model (CAPM) The CAPM The market portfolio The capital market line The risk premium on the market portfolio.
Alison Halliday, Professor of Vascular Surgery, University of Oxford 4 th April 2013 Trial update – 1169 Patients so far- Well done, what’s next? 1.
Internal 2014 - Cochrane data
Nanoparticle Gold in therapy and cosmetology
Copd journal club
Lecture Xv Arteriosclerosis And Atherosclerosis 11
